Chinese biotech companies are delivering massive beats.
Chinese biotech is the standout sector halfway through earnings season, with aggregate beats clearing estimates by almost 50%. Companies like Innovent Bio and CSPC are seeing massive earnings beats and positive market reactions.
The antitrust fine and resolution of the regulatory probe remove a major overhang on Trip.com, which had been a cloud of uncertainty over the stock, likely allowing it to recover.